Literature DB >> 24976027

Are we ready for combination therapy in moderate-to-severe ulcerative colitis?

Yeong Yeh Lee1, Venugopalareddy Gangireddy2, Sandeep Khurana2, Satish S C Rao2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24976027     DOI： 10.1053/j.gastro.2014.03.053

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  1 in total

1.  TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis.

Authors:  Bo Xiao; Qiubing Chen; Zhan Zhang; Lixin Wang; Yuejun Kang; Timothy Denning; Didier Merlin
Journal:  J Control Release       Date:  2018-08-11       Impact factor: 9.776
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.